ArticleArchives of public health = Archives belges de sante publique2026
Preferences for HIV testing services among men who have sex with men in China: a discrete choice experiment.
Article in Archives of public health = Archives belges de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHIV testing coverage among men who have sex with men (MSM) in China remains sub-optimal, hindered by stigma, economic burden and low self-perceived HIV risk. To overcome these barriers and enhance testing uptake, it is critical to investigate testing preferences among this population and evaluate how different HIV testing characteristics affect their choice of testing options.
methodsFrom March 1 to October 30, 2025, a discrete choice experiment was performed to quantify MSM's preferences across two provinces (Shandong and Guangdong) representing relatively low and high HIV prevalence in northern and southern China, respectively. Respondents were presented with hypothetical testing profiles, varying in service mode, testing accuracy, mortality reduction, testing interval, cost and time to receive test results. Mixed logit models were applied to estimate individual preferences, relative importance, willingness-to-pay (WTP) and predicted testing uptake.
resultsAmong 553 eligible respondents, 308 (55.7%) were from Shandong, with a mean (SD) age of 33.5 (10.7) years. Overall participants were mainly concerned about cost, with testing frequency, notification time and mortality reduction also playing a crucial role in motivating testing uptake, surpassing the importance of testing accuracy and mode. The highest WTP was observed for increasing the testing frequency from annual to semiannual ($28.0). The estimated testing uptake rose to over 90% if testing cost was substantially reduced. Notably, our findings illustrated complex preference dynamics and highlighted the significance of tailoring strategies. Compared with frequent testers, respondents with low-frequency testing experience showed significantly weaker preferences for health benefits and stronger preferences for higher testing accuracy. However, frequent testers ranked accuracy as the least important attribute and exhibited significantly stronger preferences for free services relative to those with limited testing experience.
conclusionsAmong MSM, the availability of semiannual testing programs led by community-based organization with greater health benefits and shorter waiting time for precise results have the potential to increase HIV testing rates, if provided for free. Our findings enrich the current understanding of testing decision-making and inform differentiated strategies. Furthermore, these results help prioritize health system innovations when resource constraints preclude the use of all strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.